NasdaqHealth CarePharmaceutical PreparationsBOSTON, MA

CervoMed Inc. CRVO

Ask your AI

Estimated market cap $25.57M15.13M shares, shares as of Nov 4, 2026CIK 1053691

Insider trades, 12 mo

9 buys · 0 sells

$3.44M bought, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

6.4% of shares · 6 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in CervoMed Inc.'s latest quarterly report, compared with the one before.

Filed Nov 6, 2026 · Quarter ended Sep 30, 2026

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in CervoMed Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

9 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Jun 11, 2026. Insiders have two business days to file.

Recent insider trades

Joshua S. Boger Director, 10% owner	Jun 11 Form 4 ↗	Buy	+$3.0M 955,414 sh @ $3.14	-33.0%
William Robert Elder CFO, GC & Secretary	Nov 18, 2025 Form 4 ↗	Buy	+$20.8K 2,500 sh @ $8.32	-93.9%
Matthew Winton Chief Commercial and Business	Nov 18, 2025 Form 4 ↗	Buy	+$11.9K 1,500 sh @ $7.95	-93.9%
Sylvie Gregoire Director, 10% owner	Nov 17, 2025 Form 4 ↗	Buy	+$91.3K 10,793 sh @ $8.46	-92.7%
William Robert Elder CFO, GC & Secretary	Nov 17, 2025 Form 4 ↗	Buy	+$8,450 1,000 sh @ $8.45	-92.7%

All CRVO insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

964,514 shares

26 funds report CRVO. Values checked against market prices.

Funds own 12% of shares (Q2 2026)

37 funds hold the stock.

Q3 2026: 6.4% · 5,560 of ~8,900 funds reported so far

Q2 202524%
Q3 202523%
Q4 202524%
Q1 202619%
Q2 202612%
Q3 2026 (so far)6.4%

Q3 2026. 1 new, 6 added to, 11 trimmed, 12 exited since Q2 2026.

Top 13F holders
#
1	Vanguard Capital Management LLC 13F ↗	316,202	$939.1K	unchanged
2	Sabby Management, LLC 13F ↗	199,678	$593.0K	-19.8%
3	Geode Capital Management, LLC 13F ↗	92,007	$273.3K	+37.5%
4	BlackRock, Inc. 13F ↗	79,663	$236.6K	+47.9%
5	Vanguard Fiduciary Trust Co 13F ↗	61,516	$182.7K	+70.2%
6	Citigroup Inc 13F ↗	39,334	$116.8K	+5823.8%
7	Citizens Financial Group Inc 13F ↗	37,477	$111.3K	unchanged
8	Savvy Advisors, Inc. 13F ↗	25,922	$77.0K	unchanged
9	Thompson Davis & Co., Inc. 13F ↗	25,900	$76.9K	-12.9%
10	State Street Corp 13F ↗	20,527	$61.0K	unchanged

Download CSV Every fund that holds CRVO, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What CervoMed Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What CervoMed Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q3 2023	12	—	363,667	$1.7M
Q4 2023	12	0	326,442	$2.5M
Q1 2024	20	+8	2.51M	$58.6M
Q2 2024	38	+18	3.45M	$59.1M
Q3 2024	50	+12	3.51M	$51.2M
Q4 2024	49	-1	1.49M	$3.5M
Q1 2025	48	-1	2.28M	$20.9M
Q2 2025	45	-3	2.18M	$13.7M
Q3 2025	45	0	2.13M	$17.3M
Q4 2025	48	+3	2.20M	$17.4M
Q1 2026	36	-12	1.77M	$7.0M
Q2 2026	37	+1	1.75M	$5.4M
Q3 2026	26	-11	964,514	$2.9M

Each point is a quarter-end, from Q3 2023 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (15713L109). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q3 2023) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes10 in 12 mo 8-K events7 in 90 days PatentsNone on record Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive pay3 fiscal years Wikipedia attentionNone on record SEC enforcementNone on record IPO history6 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: CervoMed Inc.
Address: 20 PARK PLAZA, SUITE 424, BOSTON, MA 02116
Phone: (617) 744-4400
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: DE
Listed as: CRVO (Nasdaq)
Former names: Diffusion Pharmaceuticals Inc. (until 2023); RestorGenex Corp (until 2016); Stratus Media Group, Inc (until 2014); FERIS INTERNATIONAL, INC. (until 2008); TITAN MOTORCYCLE CO OF AMERICA INC (until 2008)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$1.69−$0.14 (−7.65%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $1.37 · High $2.34Nov 13, 2026

Aug 13, 2026Low $1.37 · High $3.34Nov 13, 2026

Nov 13, 2025Low $1.37 · High $9.94Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.